Latest briefing
What's happening with DRRX PR Newswire 11 Sept 2025
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio - PR Newswire <a href="https://news.google.com/rss/articles/CBMi7wFBVV95cUxNdmk1RFFFWVNST0VNRHVUdlUtcF81SXpYMG9Qd002UUNCN1NxcW4tYWV3YWdvaDB3VlpuRXI2QXMzZ3dzOXlXZjZMTnJNVXlGWnhNZWJuRFhSc2x3NEZVN051YnpJMXQtOHFJOVZqTVV3dUNBWVZxekNHYVlaNGNSY2E1V3U2el93NzFENWx5Z2RUYzVkY0J2aGpjcTBaSzBDQmZ1S0s0ZWliUTBVbFdsaDV5bkVfaUhWb0hyNTBuVEpjRGdlS2UxX2o0UUVCMGxWUUZ1MUwxbG9pT3h6bExfcXVfSUJoRnBMeEI4VnJIUQ?oc=5" target="_blank">Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio</a> <font…
Why this matters▾
Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read. Read full article ↗ Quiver Quantitative 22 Aug 2025
DURECT Corporation Stock (DRRX) Opinions on Potential Acquisition by Bausch Health | DRRX Stock News - Quiver Quantitative <a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxPM0lxZnZiSTE1SnZWQm5zYkhkbnRJMmhDSDZLLUlYbm1qNmJDT1Jtbkw0bDIwa0dqWUdOU1F6Nzk3QTg1V2ZOOGlMYlFVQXlPOGVrdDdhVTNveFlBb1Z0bDZBeFV5Y29ULXA3TGFfSGVqLVdLbWF3T3N1VnM4SUpFWVlxUjJwaFJfcDN3ZFljMk9IVjhYQ1FKZzg3TEY2dUN2emluVEFRaVJsdjRCNXhDcUt1Ty1HNjZKeWI0?oc=5" target="_blank">DURECT Corporation Stock (DRRX) Opinions on Potential Acquisition by Bausch Health | DRRX Stock News</a> <font color="#6f6f6f">Quiver Quantitative</font>
Why this matters▾
Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read. Read full article ↗ PR Newswire 12 Aug 2025
DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health - PR Newswire <a href="https://news.google.com/rss/articles/CBMijgJBVV95cUxONlBwei1YN0hlbWNhTEdhZGkweGNSaUhfZmc1d1BxYjdiejV4bjRLaTlIMDIwUEpWQWtOYzlNZzNxS1ZXZHVmMjYybWwwTFlYaWRnaTVpMGFuQ0xtc1h1cHdocExmZWRQRnZPT1Nnd2RCX09jRGhXb0RvZmVxaHhyNkZZQUttUjdDdHd1eHBjc21FQjVNSWU4dGxXLWp1SWNBS2VXTVQzUmhWSFJOSnh2OEhCVjRYOWxtLWlxYUxTeThXTDc5ZVRYeGxRTFdxd0ZCSjAwZ0g1WnBWSnV3UlpKajFkMlJIZEtvc29GZ1lmcDBkMXlYRjFUbk5IOVB0VjhmNEtnWmFqbWhpNEdGNVE?oc=5" target="_blank">DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update…
Why this matters▾
Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read. Read full article ↗ Older updates drop into a lighter feed
Bausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease Treatment - Yahoo Finance
Read ↗ Fierce Biotech
29 Jul 2025
Bausch Health bags phase 3-ready liver prospect in $63M Durect buyout - Fierce Biotech
Read ↗ DURECT (DRRX) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
Read ↗ Earnings news
DRRX earnings headlines This section is separated from the general news feed so investors can quickly connect the latest headlines with the structured earnings report.
Beyond the headline
A deeper look for beginners Generate a short AI read that goes beyond the headlines above, plus a plain-English breakdown of what it could mean going forward.
Generate AI Insight 